Revolution Medicines (RVMD) Tax Provisions (2020 - 2024)

Revolution Medicines' Tax Provisions history runs 4 years deep, the most recent figure standing at -$800000.0 for Q4 2024.

• On a quarterly basis, Tax Provisions fell 119.09% year-over-year to -$800000.0 in Q4 2024; TTM through Dec 2024 was -$800000.0, a 346.91% decrease from a year earlier, with the FY2024 full-year figure at -$800000.0, down 346.91% from the prior year.
• Tax Provisions fell to -$800000.0 in Q4 2024 per RVMD's latest filing, from $4.2 million in the prior quarter.
• Across five years, Tax Provisions topped out at $4.2 million in Q4 2023 and bottomed at -$3.9 million in Q3 2023.
• The 4-year median for Tax Provisions is -$200000.0 (2022), against an average of -$155875.0.
• Biggest YoY gain for Tax Provisions was 4168.93% in 2023; the steepest drop was 1202.02% in 2023.
• Year by year, Tax Provisions stood at $362000.0 in 2020, then slumped by 128.45% to -$103000.0 in 2022, then soared by 4168.93% to $4.2 million in 2023, then tumbled by 119.09% to -$800000.0 in 2024.
• Per Business Quant, the three latest RVMD Tax Provisions figures stand at -$800000.0 (Q4 2024), $4.2 million (Q4 2023), and -$3.9 million (Q3 2023).